Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Therese M Mulvey

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Annals of Surgical Oncology|July 20, 2020
Baseline Screening MRI Uptake and Findings in Women with ≥ 20% Lifetime Risk of Breast CancerAlison Laws, Therese M Mulvey, Nicole Jalbert, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 6, 2020
The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US populationKassidy Beyerlin, Rachel Jimenez, Mark Zangardi, et al.
The Oncologist|October 12, 2020
Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient SettingSienna M Durbin, Leyre Zubiri, Andrzej Niemierko, et al.
JCO Oncology Practice|July 28, 2021
Telehealth in Oncology: ASCO Standards and Practice RecommendationsRobin T Zon, Erin B Kennedy, Kerin Adelson, et al.
JCO Oncology Practice|July 21, 2025
Oncology Medical Homes: ASCO-Community Oncology Alliance StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Breast Cancer Research and Treatment|June 13, 2021
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)Kathryn J Ruddy, Yue Zheng, Nabihah Tayob, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Annals of Surgical Oncology|July 20, 2020
Baseline Screening MRI Uptake and Findings in Women with ≥ 20% Lifetime Risk of Breast CancerAlison Laws, Therese M Mulvey, Nicole Jalbert, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|November 6, 2020
The adjuvant use of capecitabine for residual disease following pre-operative chemotherapy for breast cancer: Challenges applying CREATE-X to a US populationKassidy Beyerlin, Rachel Jimenez, Mark Zangardi, et al.
The Oncologist|October 12, 2020
Clinical Outcomes of Patients with Metastatic Cancer Receiving Immune Checkpoint Inhibitors in the Inpatient SettingSienna M Durbin, Leyre Zubiri, Andrzej Niemierko, et al.
JCO Oncology Practice|July 28, 2021
Telehealth in Oncology: ASCO Standards and Practice RecommendationsRobin T Zon, Erin B Kennedy, Kerin Adelson, et al.
JCO Oncology Practice|July 21, 2025
Oncology Medical Homes: ASCO-Community Oncology Alliance StandardsKim Woofter, Erin B Kennedy, Kerin Adelson, et al.
Breast Cancer Research and Treatment|June 13, 2021
Chemotherapy-related amenorrhea (CRA) after adjuvant ado-trastuzumab emtansine (T-DM1) compared to paclitaxel in combination with trastuzumab (TH) (TBCRC033: ATEMPT Trial)Kathryn J Ruddy, Yue Zheng, Nabihah Tayob, et al.
Pageof 2